Figure 3.

Effect of zoledronate on farnesylation status of HDJ2. Prostatic cells where treated for 48 h with ZOL (20 μM), lysed in hot (90°C) SDS (1%) and analyzed by Western blot.

Goffinet et al. BMC Cancer 2006 6:60   doi:10.1186/1471-2407-6-60
Download authors' original image